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Abstract
Background: This cross-sectional and prospective study used a variety of psychological inventories to evaluate
the relationship between psychosocial factors and the glycemic control of patients with type 2 diabetes.
Methods: Participants were 304 patients with type 2 diabetes who were treated as outpatients at diabetes clinics.
All participants were assessed for HbA1c and completed the following self-report psychological inventories: 1)
Diabetes Treatment Satisfaction Questionnaire (DTSQ), 2) Problem Areas in Diabetes Survey (PAID), 3) Well-
being Questionnaire 12 (W-BQ12), 4) Self-Esteem Scale (SES), 5) Social Support Scale, and 6) Self-Efficacy Scale.
HbA1c was again measured one year later. The relationships between the psychosocial variables obtained by
analysis of the psychological inventories and baseline or one-year follow-up HbA1c were determined.
Results: Baseline HbA1cwas significantly correlated with age, diet treatment regimen, number of microvascular
complication of diabetes, and the total scores of DTSQ, W-BQ12, PAID, SES and the Self-Efficacy Scale.
Hierarchical stepwise multiple regression revealed that significant predictors of baseline HbA1c were total DTSQ
and PAID scores, along with age, diet treatment regimen, and number of microvascular complication of diabetes
after adjustment for demographic, clinical and other psychosocial variables. Two hundred and ninety patients
(95.4% of 304) were followed and assessed one year after baseline. Hierarchical stepwise multiple regression
analysis showed the significant predictors of follow-up HbA1c to be total DTSQ and PAID scores, along with age
and diet treatment regimen. However, the correlation between baseline and follow-up HbA1c was so high that
the only other variable to retain significance was diet treatment regimen once baseline HbA1c was included in the
regression of follow-up HbA1c.
Conclusion: The DTSQ and the PAID predicted both current and future HbA1c to a similar and significant degree
in patients with type 2 diabetes.
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The clinical course of diabetes, especially glycemic con-
trol, is largely influenced by patient self-management. The
success of self-management is rather dependant on psy-
chosocial aspects at the individual, interpersonal, social,
and community levels. Fewer studies of the relationship
between glycemic control and psychosocial factors have
been conducted for type 2 diabetes than for type 1 diabe-
tes. In cross-sectional research on type 2 diabetes, self-effi-
cacy [1-3] and diabetes coping [4] were associated with
good treatment adherence and good glycemic control,
whereas stressful life events [5] and daily environmental
stress factors [6] have been shown to be associated with
poor metabolic control. Depression has been shown to
have a significant association with increased HbA1c [7,8].
In other reports, anxiety was associated with hyperglyc-
emia [9], diabetes-specific distress influenced poor adher-
ence and poor glycemic control [10,11], and high self-
esteem [12] and social support [13] were found to relate
to good adherence. Moreover, the patient-physician inter-
personal relationship was reported to be a contributor to
better diabetes outcomes [14]. However, only a few longi-
tudinal [1,15]studies have examined the relationship
between psychosocial factors and glycemic control in type
2 diabetes.
The aim of the present study was to do a prospective and
cross-sectional investigation to clarify the relationship
between various psychosocial variables and glycemic con-
trol in Japanese patients with type 2 diabetes to determine




Participants were 304 Japanese type 2 diabetes patients
who were treated in outpatient diabetes clinics. Well-
trained specialists in diabetes diagnosed patients accord-
ing to the latest criteria of the Japan Diabetes Society: A
fasting plasma glucose level of ≥ 126 mg/dl or an oral glu-
cose-tolerance test with a 2-hour post-load plasma glu-
cose level of ≥ 200 mg/dl. Causal plasma glucose > 200
mg/dl was also regarded as diabetes. The study was
approved by the ethics committees of Kitakyushu City
Hospital, Tokushukai Hospital, and Iki Municipal Hospi-
tal, all of which are central hospitals in the region. The
aim of the present study, as described in the background
section, was explained to the patients orally and in writing
by their physicians, who also distributed and collected the
questionnaire booklets and obtained written informed
consent.
Psychological measures
The questionnaire consisted of six psychosocial invento-
ries.
1) The Diabetes Treatment Satisfaction Questionnaire
(DTSQ) consists of eight items, each with seven possible
answers. Six of the eight items are designed specially to
measure a person's satisfaction with their diabetes treat-
ment regimen [16]. Two additional items are concerned
with the perceived frequency of hypo- and hyper-glyc-
emia, which are scored separately as single items. In the
present study, the total score of the six items was used as
the treatment satisfaction scale. The range of total scores
obtained by summing these six items from the DTSQ is
from 0 to 36. We used the Japanese version of the DTSQ,
which was linguistically and psychometrically evaluated
by Ishii et al [17]. Cronbach's alpha for the total scores of
the six items was 0.857 in the present study.
2) The Well-being Questionnaire 12 (W-BQ12) consists
of 12 items and is a shortened version of the 22 item W-
BQ that was designed to measure the psychological well-
being of people with diabetes [18]. Items concerning
somatic symptoms were avoided as they may lead to crite-
rion contamination in populations with diabetes, where
somatic symptoms such as fatigue or loss of appetite may
be due to the physical condition of diabetes rather than to
depression. We used the Japanese version of the W-BQ 12
that was linguistically and psychometrically evaluated by
Riazi et al. [19]. Cronbach's alpha for the overall scale
score in the present study was 0.928.
3) The Problem Areas in Diabetes Scale (PAID) is a meas-
ure of diabetes-specific emotional distress that was devel-
oped by Polonsky et al. [10] and translated into Japanese
by Ishii et al. [20]. The scale consists of 20 items. There are
five response options available for each PAID question:
These responses are given a value from 0 (not a problem)
to 4 (serious problem). According to the recommendation
of the measure's authors, a total score was computed by
summing the total item responses and multiplying this
total by 1.25 to produce a total score that ranges from 0–
100. Cronbach's alpha was 0.950 in the present study. 4)
Self esteem was measured by use of the Rosenberg Self-
esteem Scale (SES) [21]. The SES is a self-report question-
naire and consists of 10 items. Five of the items are
phrased as positive and five as negative statements. Each
item is answered according to a five-point scale, where a
higher total score represents higher self-esteem. We used
the Japanese version of the SES for which high internal
consistency and construct validity have been confirmed
[22]. Cronbach's alpha was 0.736 in the present study.
5) The Social Support Scale for patients with chronic dis-
ease (heart disease, diabetes mellitus, hypertension, etc.)
was developed in Japan by Kim et al. [23]. The scale con-
sists of 20 items related to social support in daily life for
chronic disease and is divided into two subscales: emo-
tional support in daily life and behavioral support for dis-Page 2 of 8
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all) to 4 (very applicable). The total score range extends
from 4 to 80. A higher score represents higher social sup-
port in daily life. This test has high reliability and validity
for each scale. Cronbach's alpha for the total score was
0.954 in the present study.
6) The Self-Efficacy Scale for health behaviors that influ-
ence health promotion in chronic disease patients was
developed in Japan by Kim et al. [24]. The scale consists of
20 items and two subscales: active coping behavior with
disease and controllability for health. Each item is scored
on a Likert scale from 1 (not at all) to 4 (very applicable).
The score range extends from 4 to 80. A higher score rep-
resents higher self-efficacy in dealing with health behav-
ior. This test has high reliability and validity for each scale.
Cronbach's alpha for the total score was 0.928 in the
present study.
Clinical variables
Demographic and clinical data were collected from medi-
cal records on the date closest to the start of the study. The
HbA1c level was measured using high-performance liquid
chromatography, with a normal reference range of 4.3%–
5.8%. The diabetes treatment regimen consisted of either
diet only or medication, which included oral hypoglyc-
emic agents (OHA) or insulin or insulin plus OHA. The
presence of microvascular complications of diabetes was
determined as follows: 1) diabetic neuropathy was
defined by clinical symptoms or by neurological examina-
tion; 2) diabetic retinopathy was diagnosed and assessed
by an ophthalmologist; 3) diabetic nephropathy was diag-
nosed as the presence of prolonged microalbuminuria
defined according to the consensus statement of the
American Diabetes Association [25].
One-year follow-up data collection
Of the 304 patients who completed the questionnaire at
baseline, 32 were referred to local clinics near their resi-
dence because they had relatively good glycemic control
(mean HbA1c = 6.8%). Six of these 32 patients dropped
out of treatment at the referred clinic. Four patients in our
central hospitals also dropped out of treatment and four
patients died within one year. Thus, 290 patients followed
for one year had complete data available for analysis (fol-
low-up rate 96.5%). The demographic, clinical and psy-
chosocial data at baseline were not significantly
differentbetween the 290 patients who were followed for
the whole year and the 14 patients who dropped out,
whether calculated by the total of 14 or divided as 10 con-
tinuing patients and four deceased patients.
Statistical analysis
Pearson's simple correlation test was done to search for
associations between HbA1c and demographic, clinical,
and psychosocial variables and for the correlation of each
psychosocial variable. A hierarchical multiple regression
analysis was done as a model for predicting current (base-
line) and future (one-year follow-up) HbA1c. The follow-
ing sequence was followed: first, demographic and
clinical variables were entered as model 1; second, all psy-
chosocial variables other than DTSQ or PAID score were
added to model 1 as model 2 or model 3. Because DTSQ
and PAID scores had a relatively high correlation, they
were entered separately in the model to avoid multicol-
linearity; third, baseline HbA1c was added to models 2 and
3 as models 4 and 5 for predicting one-year follow-up
HbA1c. Dummy codes were applied to sex, male = 1 and
female = 0, and to treatment regimen, diet only = 1 and
medication = 0, in Pearson's correlation test and multiple
regression analysis. Comparison of demographic, clinical,
and psychosocial variables between patients followed or
not followed for one year was done by Student's t-test or
χ2 test. Comparison between baseline and follow-up
HbA1c was done by Student's paired t-test. Cronbach's
alpha was used to assess the internal consistency of the
total score of each psychological test. All statistical analy-
ses were performed with the SPSS software package (ver-
sion 12.0J for Windows). Statistical significance was set at
0.05.
Results
Table 1 shows the baseline demographic, clinical and psy-
chosocial characteristics of our patients with type 2 diabe-
tes. There were no significant differences in any
demographic, clinical, or psychosocial factors between
patients followed for one year (n = 290) and those who
could not be followed (n = 14). Also, even after eliminat-
ing the four deceased patients, there were no significant
differences in any of the demographic, clinical, or psycho-
social variables between the remaining 10 patients who
were not followed for the full year and the 290 patients
who were. Moreover, although six of 10 patients who
dropped out were referred to local clinics because of good
glycemic control, there were no significant differences in
any variables between the 290 patients completing fol-
low-up and the six referred patients. In addition, of the 32
patients who were referred to local clinics, the 6 dropouts
and 26 patients who did not drop out had no significant
differences in any of the variables (data not shown).
Table 2 shows a correlation matrix of the total scores of
the psychosocial inventories of the 304 patients at base-
line. The DTSQ had significant, positive correlations with
the W-BQ12 (correlation coefficient (r) = 0.254), SES (r =
0.128), Social Support Scale (r = 0.176), and Self-Efficacy
Scale (r = 0.448) and a negative correlation with the PAID
(r = -0.489). The W-BQ12 had significant positive correla-
tions with the SES (r = 0.479), Social Support Scale (r =
0.314), and Self-Efficacy Scale (r = 0.525) and a significantPage 3 of 8
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score revealed significant negative correlations with all the
other psychosocial variables, including the SES (r = -
0.322), Social Support Scale (r = -0.169) and the Self-Effi-
cacy Scale (r = -0.437). The SES showed a significant pos-
itive correlation with the Social Support Scale (r = 0.273)
and the Self-Efficacy Scale (r = 0.401). A positive, signifi-
cant correlation was found between the Social Support
Scale and the Self-Efficacy Scale (r = 0.404).
Table 3 displays the results of correlation coefficients by
Pearson's simple correlation test and standard regression
coefficients (β) by hierarchical stepwise multiple regres-
sion for the demographic, clinical and psychosocial varia-
bles and HbA1c at baseline. Baseline HbA1c was found to
have significant positive correlations with, the number of
diabetic complications (r = 0.168) and the baseline PAID
score (r = 0.220), meaning that greater distress on diabetes
was associated with a worse HbA1c value. In contrast, base-
line HbA1c was found to have significant negative correla-
tions with age (r = -0.311), diet treatment regimen (r = -
0.249), and the baseline scores of the DTSQ (r = -0.219),
W-BQ12 (r = -0.125), and Self-Efficacy Scales (r = -0.187),
meaning that greater satisfaction, well-being and self-effi-
cacy on diabetes were associated with a better HbA1c
value. The hierarchical stepwise multiple regression
model revealed that age, diet treatment regimen, and
number of diabetes complications were significantly and
independently associated with baseline HbA1c (Table 3,
model 1, R2 = 0.164). In model 2 (R2 = 0.178), the DTSQ
Table 1: Baseline demographic, clinical and psychosocial characteristics of patients with type 2 diabetes
Total followed for one year (a) not followed (n = 14)





Sex(M/F) 170/134 161/129 6/4 3/1
Age (y) 61.9 ± 11 61.1 ± 11 57.4 ± 12 70.5 ± 8.2
Duration of illness (y) 11.6 ± 8.1 11.6 ± 10 8.8 ± 7.2 14.0 ± 3.6
Clinical variables
HbA1c (%) 7.30 ± 1.2 7.32 ± 1.2 6.72 ± 0.88 7.83 ± 1.3
Treatment regimen (diet only/medication) 63/241 59/231 4/6 0/4
No. of microvascular complications of diabetes (0/1/2/3) 116/79/60/49 107/77/60/46 9/0/0/1 0/2/0/2
Psychosocial variables (score)
DTSQ 25.3 ± 6.4 25.2 ± 6.4 28.0 ± 5.5 26.3 ± 7.4
W-BQ12 23.8 ± 6.7 23.8 ± 6.6 25.5 ± 8.1 20.0 ± 9.1
PAID 33.0 ± 21 33.4 ± 21 21.5 ± 23 37.2 ± 25
SES 35.2 ± 6.2 35.3 ± 6.2 32.6 ± 6.9 38.3 ± 5.4
Social Support Scale 56.2 ± 17 56.4 ± 16 48.1 ± 18 61.3 ± 22
Self-Efficacy Scale 74.0 ± 12 73.9 ± 12 75.9 ± 13 76.0 ± 8.8
Values are mean ± SD or n. Medication, oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment 
Satisfaction Questionnaire measures satisfaction with the current therapy for diabetes; W-BQ12, Well-being Questionnaire12 measures the 
psychological well-being of patients with diabetes; PAID, Problem Areas in Diabetes Scale measures diabetes-specific emotional distress; SES, Self-
Esteem Scale measures global self-esteem; Social Support Scale measures the degree of social support in daily life for chronic disease; Self-Efficacy 
Scale measures self-efficacy in dealing with health behavior in chronic disease.
Table 2: Correlation matrix of psychosocial variables at baseline (n = 304)
Psychosocial variable
Psychosocial variable 1 2 3 4 5 6
1 DTSQ -
2 W-BQ12 0.254** -
3 PAID -0.489** -0.555** -
4 SES 0.128** 0.479** -0.322** -
5 Social Support Scale 0.176** 0.314** -0.169** 0.273** -
6 Self-Efficacy Scale 0.448** 0.525** -0.437** 0.401** 0.404** -
Value is correlation coefficient (r). **P < 0.01.
DTSQ, Diabetes Treatment Satisfaction Questionnaire; W-BQ12, Well-being Questionnaire12;
PAID, Problem Areas in Diabetes Scale; SES, Self-Esteem Scale. Each measure is detailed in the footnotes of Table 1.Page 4 of 8
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Table 3: Simple correlation coefficients (r) and standard regression coefficients by hierarchical stepwise multiple regression (β) 
between baseline variables and HbA1c at baseline of patients with type 2 diabetes (n = 304).
Hierarchical stepwise regression analysis
Simple correlation Model 1 Model 2 Model 3
Baseline variables r P β P β P β P
Sex (male = 1, female = 0) -0.047 0.148 - - - - - -
Age -0.311 <0.001 -0.316 <0.001 -0.296 <0.001 -0.295 <0.001
Duration of illness 0.051 0.376 - - - - -
Treatment regimen (diet only = 1, medication = 0) -0.249 <0.001 -0.177 0.001 -0.155 0.005 -0.157 0.005
No. of microvascular complications of diabetes 0.168 <0.001 0.177 0.001 0.170 0.003 0.163 0.003
DTSQ -0.219 <0.001 NI NI -0.120 0.030 NI NI
W-BQ12 -0.125 0.030 NI NI - - - -
PAID 0.220 <0.001 NI NI NI NI 0.131 0.017
SES -0.030 0.607 NI NI - - - -
Social Support Scale -0.052 0.367 NI NI - - - -
Self-Efficacy Scale -0.187 <0.001 NI NI - - - -
Adjusted R2 0.164 0.178 0.178
F 20.8 <0.001 17.2 <0.001 17.2 <0.001
Medication, oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment Satisfaction Questionnaire; 
W-BQ12, Well-being Questionnaire12; PAID, Problem Areas in Diabetes Scale; SES, Self-Esteem Scale. Each measure is detailed in the footnotes of 
Table 1. R2, multiple coefficient of determination. NI, not included. Model 1, adjusted for sex, age, duration of illness, treatment regimen, number of 
microvascular complications of diabetes; Model 2, adjusted for Model 1 and DTSQ, W-BQ12, SES, Social Support Scale, Self-Efficacy Scale; Model 3, 
adjusted for Model 1 and W-BQ12, PAID, SES, Social Support Scale, Self-Efficacy Scale.
Table 4: Simple correlation coefficients (r) and standard regression coefficients by hierarchical stepwise multiple regression (β) 
between baseline variables and HbA1c at 1 year follow-up of patients with type 2 diabetes (n = 290).
Hierarchical stepwise regression analysis
Simple correlation Model 1 Model 2 Model 3 Model 4 Model 5
Baseline variables r P β P β P β P β P β P
Sex (male = 1, female = 0) -0.106 0.071 - - - - - - - - - -
Age -0.219 <0.001 -0.180 0.001 -0.153 <0.001 -0.154 0.001 - - - -
Duration of illness 0.016 0.788 - - - - - - - - -
Treatment regimen
(diet only = 1, medication = 0)
-0.318 <0.001 -0.294 <0.001 -0.278 0.001 -0.274 <0.001 -0.155 0.001 -0.155 0.001
No. of microvascular
complications of diabetes
0.102 0.082 - - - - - - - - - -
DTSQ -0.202 0.001 NI NI -0.115 0.030 NI NI - - NI NI
W-BQ12 -0.137 0.020 NI NI - - - - - - - -
PAID 0.220 <0.001 NI NI NI NI 0.140 0.014 NI NI - -
SES -0.095 0.108 NI NI - - - - - - - -
Social Support Scale -0.054 0.358 NI NI - - - - - - - -
Self-Efficacy Scale -0.166 0.001 NI NI - - - - - - - -
HbA1c 0.675 <0.001 NI NI NI NI NI NI 0.638 <0.001 0.634 <0.001
Adjusted R2 0.127 0.138 0.144 0.479 0.474
F 22 <0.001 16.2 <0.001 17.0 <0.001 132 <0.001 130 <0.001
Medication: oral hypoglycemic agents, or insulin, or insulin plus oral hypoglycemic agents. DTSQ, Diabetes Treatment Satisfaction Questionnaire; 
W-BQ12, Well-being Questionnaire12; PAID, Problem Areas in Diabetes Scale; SES, Self-Esteem Scale. Each measure is detailed in the footnotes of 
Table 1. R2, multiple coefficient of determination. NI, not included. Model 1, adjusted for sex, age, duration of illness, treatment regimen, number of 
microvascular complications of diabetes; Model 2, adjusted for Model 1 and DTSQ, W-BQ12, SES, Social Support Scale, Self-Efficacy Scale; Model 3, 
adjusted for Model 1 and W-BQ12, PAID, SES, Social Support Scale, Self-Efficacy Scale; Model 4, adjusted for Model 2 and HbA1cat baseline; Model 
5, adjusted for Model 3 and HbA1c at baseline.
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-0.120, P = 0.03) after controlling for demographic, clini-
cal, and psychosocial variables, except for PAID score. In
model 3 (R2 = 0.178), the PAID score was significantly
related to baseline HbA1c (β = 0.131, P = 0.017) after con-
trolling for demographic, clinical, and psychosocial varia-
bles, except for the DTSQ score. However, no more than
17.8% of the variance in current glycemic control was
accounted for by age, diet treatment regimen, number of
diabetes complications, and DTSQ or PAID score.
Table 4 displays the results by Pearson's simple correla-
tion test and hierarchical stepwise multiple regression for
baseline demographic, clinical and psychosocial variables
and one-year follow-up HbA1c. HbA1c at the one-year fol-
low-up was found to have significant positive correlations
with the baseline PAID score and to have a significant neg-
ative correlation with age, diet regimen, and the baseline
scores of the DTSQ, W-BQ12, SES and Self-Efficacy Scale.
A highly significant positive correlation was found
between baseline HbA1c and one-year follow-up HbA1c (r
= 0.675, P < 0.01). In addition, HbA1c at the one-year fol-
low-up (7.15 ± 1.2%) had significantly better values than
the baseline HbA1c (7.32 ± 1.2%) of the 290 patients (P =
0.02 by paired t-test). The hierarchical stepwise multiple
regression for one-year follow-up HbA1c as a dependent
variable revealed that age and diet treatment regimen were
significantly and independently associated with follow-up
HbA1c (Table 4, model 1, R2 = 0.127). In model 2 (R2 =
0.138), DTSQ score was significantly associated with fol-
low-up HbA1c (β = -0.115, P = 0.03) after controlling for
demographic, clinical, and psychosocial variables, except
for PAID score. In model 3 (R2 = 0.144), PAID score was
significantly related to follow-up HbA1c (β = 0.140, P =
0.014) after controlling for demographic, clinical, and
psychosocial variables, except for DTSQ score. By adding
baseline HbA1c to model 2, 47.9% of the variance in
future glycemic control was accounted for by treatment
regimen (β = -0.155, P = 0.001) and baseline HbA1c (β =
0.638, P < 0.001) in model 4. Also, by adding baseline
HbA1c to model 3, 47.4% of the variance in future glyc-
emic control was accounted for by treatment regimen (β =
-0.155, P = 0.001) and baseline HbA1c (β = 0.634, P <
0.001) in model 5. The results of models 4 and 5 indicate
that better current HbA1c and diet treatment are significant
predictors of better future HbA1c. The statistically signifi-
cant contribution of the DTSQ and the PAID to future
HbA1c disappeared after adjustment for baseline HbA1c.
Concerning treatment regimen, medication details (n =
231) are as follows: 74% of the patients on medication
were treated with OHA (n = 171) and 26% were treated
with insulin alone or insulin plus OHA (n = 60). After the
one-year follow-up, the change of HbA1c in patients who
were treated with diet only was from 6.71 ± 1.1% to 6.42
± 0.82% (P = 0.022), the change in patients who were
treated with OHA was from 7.32 ± 1.0% to 7.23 ± 1.1% (P
= 0.265), and the change in patients who were treated
with insulin or insulin plus OHA was from 7.93 ± 1.4% to
7.60 ± 1.4% (P = 0.012).
Discussion
In the present study, the relation between psychosocial
variables and glycemic control was investigated cross-sec-
tionally and prospectively. The DTSQ and the PAID pre-
dicted both current and future HbA1c to a similar and
significant degree in patients with type 2 diabetes.,, It has
been reported that the PAID score of female patients with
type 1 and type 2 diabetes who inject insulin is signifi-
cantly related to HbA1c at one-year follow-up, even after
adjustment for baseline HbA1c [11]. However, the amount
of variance accounted for by the PAID in predicting one-
year follow-up HbA1c was very small, whereas baseline
HbA1c accounted for the majority of variance for follow-
up HbA1c in the study. Therefore, the contribution of the
PAID as predictor of future glycemic control does not
seem so important. In the same way, the higher DTSQ
score of the tablet-treated patients was significantly asso-
ciated with current lower HbA1c [26]. No previous study
has investigated whether or not the DTSQ is predictive of
future glycemic control.
Both the DTSQ and the PAID, however, predicted future
glycemic control in the present study when baseline
HbA1c was not included in the regression of follow-up
HbA1c. Baseline glycemic control was fair and the glyc-
emic control was improved significantly after one year,
but the degree of glycemic improvement was 0.17% of
HbA1c, which was not so large. Under the usual treatment,
the effect of psychosocial variables on future glycemic
control could not help but being small because the corre-
lation between current and future HbA1c is so high. Thus,
in some situations where glycemic control is expected to
improve much through behavioral or psychological ther-
apeutic intervention or education programs, or alteration
of treatment regimen [11,26,27], both DTSQ and PAID
scales would predict the future glycemic condition regard-
less of current metabolic variables.
The only variable to retain significance in the regression of
the follow-up HbA1c model was treatment regimen, even
after adjustment for baseline HbA1c. This suggests that the
patients with diet alone were appropriately treated,
whereas the medication, including OHA, was not suffi-
cient. In fact, patients who were treated with OHA did not
improve over the year of the study, indicating that treat-
ment of patients with OHA was insufficient.
It should be noted that the psychosocial variables dealt
with in this study correlated significantly with each other.Page 6 of 8
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high inverse correlation. The focus of the PAID is on the
extent to which people have negative experiences with no
attention given to positive experiences, while the DTSQ
deals with the full range of experiences of treatment, from
very satisfied to very dissatisfied. We are better able to
understand the psychology of patients with diabetes by
measuring both positive and negative psychosocial
aspects. Furthermore, because the DTSQ and PAID are
associated with current and future HbA1c at almost the
same level, both tests are very useful when we want to
know the contribution of psychosocial factors to current
and future glycemic control.
Nakahara et al. [15] recently reported a longitudinal
assessment of the causal relationship between psychoso-
cial variables and glycemic control in patients with type 2
diabetes using a structural-equation model. They found
that self-efficacy directly reinforced adherence and that
adherence had a direct positive relation to good future gly-
cemic control. Diabetes-specific distress affected glycemic
control indirectly through self-efficacy. This is reasonable
because we would expect that those people who felt able
to manage their diabetes well would be more likely to do
so than people who felt they were not able to do so. In our
study, therefore, the outcome that more emotional varia-
bles, such as satisfaction for diabetes treatment and diabe-
tes-specific distress, are related to future glycemic control
is meaningful.
The present study has several limitations. First, it is
unclear concerning causal relationships among the psy-
chosocial variables tested and glycemic control because a
causal model was not applied. Second, we did not exam-
ine self-care or adherence, which is thought to influence
glycemic control directly. Therefore, the detailed mecha-
nisms of the psychosocial variables tested on glycemic
control remain unknown. Third, we could not follow 14
patients for the full year, including four patients who died.
It was thought likely that these patients were more dissat-
isfied with their treatment or were more distressed about
their diabetes than the patients who completed the fol-
low-up. However, there were no significant differences in
any of the demographic, clinical, or psychosocial variables
at baseline between patients followed for one year (n =
290) and those who could not be followed (n = 14) or
even when eliminating the four deceased patients. There-
fore, negligible bias was noted when the analysis was
done with either 14 or 10 patients as dropouts.
Conclusion
The DTSQ and the PAID predicted both current and future
HbA1c to a similar and significant degree in patients with
type 2 diabetes. However, the correlation between current
and future HbA1c was so high that the only other variable
to retain significance was treatment regimen when base-
line HbA1c was included in the regression of future HbA1c.
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